Kura Oncology Inc buy melinda
Start price
06.06.17
/
50%
€7.44
Target price
05.07.17
€8.57
Performance (%)
15.51%
End price
05.07.17
€8.60
Summary
This prediction ended on 05.07.17 with a price of €8.60. The prediction had a final performance of 15.51%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kura Oncology Inc | 0.802% | 0.802% | 32.606% | -36.639% |
| iShares Core DAX® | 0.271% | 2.504% | 3.327% | 50.436% |
| iShares Nasdaq 100 | 1.884% | 3.490% | 35.658% | 88.226% |
| iShares Nikkei 225® | 3.579% | 8.127% | 56.653% | 65.166% |
| iShares S&P 500 | 0.151% | 1.918% | 24.108% | 64.489% |
Comments by melinda for this prediction
In the thread Kura Oncology Inc diskutieren
Healthcare | Biotechnologie | USA
Anzeige der Phase 2 mit den Daten auf der Konferenz der European Hematology Association (EHA) ab Juni 22-25 2017. Das genaue Datum TBC.
Stopped prediction by melinda for Kura Oncology Inc
Kura Oncology Inc
Start price
Target price
Perf. (%)
€10.64
06.11.18
06.11.18
€14.34
10.12.18
10.12.18
16.15%
10.12.18
10.12.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€15.33
23.09.18
23.09.18
€16.51
06.11.18
06.11.18
-27.37%
06.11.18
06.11.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€8.45
10.08.17
10.08.17
€10.50
15.08.17
15.08.17
-25.44%
15.08.17
15.08.17